The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Who goes first? Patterns of cancer drug approvals across four major regulatory authorities: EMA, FDA, Health Canada, and PMDA.
 
Jeremy Lyle Warner
Stock and Other Ownership Interests - HemOnc.org
Consulting or Advisory Role - Flatiron Health; Melax Tech; Westat
Other Relationship - HemOnc.org
 
Sanjay Mishra
Employment - MilliporeSigma (I)
Other Relationship - National Geographic
 
Matthew James Hadfield
No Relationships to Disclose
 
Bishal Gyawali
Consulting or Advisory Role - Vivio Health
 
Andrew Cowan
Stock and Other Ownership Interests - Doximity
Honoraria - Curio Science; MJH Healthcare Holdings, LLC; Plexus
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Bristol-Myers Squibb/Celgene/Juno; Janssen; Secura Bio
Research Funding - Abbvie (Inst); Adaptive Biotechnologies (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Harpoon therapeutics (Inst); Janssen (Inst); Nektar (Inst)
 
Ali Raza Khaki
Honoraria - HMP; OncLive/MJH Life Sciences
Consulting or Advisory Role - Gilead Sciences (Inst)
Research Funding - 23andMe (Inst); Janssen Oncology (Inst)
Other Relationship - Tempus
(OPTIONAL) Uncompensated Relationships - Janssen; Seattle Genetics/Astellas
 
Samantha Gage
No Relationships to Disclose
 
Mark Lythgoe
No Relationships to Disclose